Column - October 3, 2023
EU’s proposed pharma legislation may backfire for access to new medicines
The newly proposed EU pharmaceutical legislation aims to increase access to medicines for patients in all EU member states, but as the proposed changes in intellectual property rights for new drugs put European innovation at risk it may have the opposite effect. The European Commission put forth its long-awaited proposal for the new European pharmaceutical […]